Berliner Tageblatt - WADA founder Pound says 'disgusted' by USADA 'lies' over China cases

Pound's comments came during an extraordinary meeting of the WADA Foundation Board, held online, to discuss the fall-out from the case of 23 Chinese swimmers who tested positive for a prescription heart drug.

WADA came under fire in April after it was revealed that the Chinese swimmers tested positive for trimetazidine -- which can enhance performance -- ahead of the Tokyo Olympics in 2021.

The swimmers were not suspended or sanctioned after WADA accepted the explanation of Chinese authorities that the results were caused by food contamination at a hotel where they had stayed.

The head of USADA, Travis Tygart, has called the situation a "potential cover-up" with the positive tests never made public at the time.

"On behalf of WADA, I am deeply disappointed and disgusted by the deliberate lies and distortions coming from USADA, including that WADA has swept doping cases in China under the rug," said Pound, a lawyer who was the first president of WADA but retired at the end of 2020.

"That accusation, bereft of any truth, has but a single purpose, to deliberately damage the reputation of WADA and to lessen the worldwide trust that has been built up since WADA was created a quarter of a century ago to head up the international fight against doping in sport.

"The claim that WADA has in some way inappropriately favored China is completely false. WADA applies the World Anti-Doping Code and the related standards in an even-handed way," he said.

Pound said that WADA's past actions against doping cases in Russia proved that "Superpowers are treated the same way" as other nations.

The former swimmer, who remains an honorary member of the International Olympic Committee, suggested that USADA's actions may have a political dimension.

"USADA is financed by the United States government. That government is currently in a chilly relationship with China's government. Could there be a connection?" he asked.

WADA has asked an independent prosecutor to examine the case and publish a report but Pound urged them to go further.

"My suggestion is twofold," he said, directly addressing WADA president Witold Banka.

"First, to wait for the report of the independent investigator and then to institute legal proceedings claiming significant damages against USADA since there must be serious consequences arising from its outrageous conduct," he said.

- 'Nothing was hidden' -

USADA did not immediately respond to a request for comment.

Pound noted that China had brought the cases to WADA originally.

"What evidence has been produced to suggest that China has benefited in any way?

"Unlike many other cases in other countries, the Chinese (anti-doping body) reported positive tests in the WADA system. Nothing was hidden.

"The Chinese investigation led to a conclusion of contamination, not doping. The evidence pointed firmly in that direction. None pointed to doping," he said.

Banka, in his opening comments, said that he had been previously attacked by Russian officials and by Chinese fans of Chinese swimmer Sun Yang, who received a doping ban.

"Today it is the US Anti Doping Agency which accuses WADA of bias towards China...so perhaps all the abuse that WADA receives is the best proof that we are a truly independent organization," he said.

"There are gaps in harmonising anti-doping policy globally...including in the United States where the great majority of these unsubstantiated and defamatory attacks have been coming from," said Banka, who went on to highlight issues he saw in the USA.

"In the U.S, 90 per cent of American athletes, those in the professional leagues and college sport, do not compete under the World Anti-Doping Code.

"31 per cent of American athletes under the code, were not sufficiently tested in the 12-month period prior to the Tokyo Games, according to the data which is available to us," he added.

He said WADA's studies had found "There are massive, massive purchases in the U.S market for PED's (performance enhancing drugs) and pharmaceutical products".

G.Schulte--BTB